ABSTRACT. It is well known that cellular interactions, such as cell adhesion, migration, invasion, between cells and the extracellular matrix are mediated by the integrin family of cell surface receptors. Chondrocytes are surrounded by an abundant extracellular matrix, but there is less information on the cellular receptors which interact with this matrix. In our studies, fibronectin, type I collagen, and type II collagen promoted haptotactic and chemotactic migration of chondrocytes, as determined using a modified Boyden chamber system. Treatment of chondrocytes with tyrosine kinase inhibitor, herbimycin or genistein, resulted in a dose dependent inhibition of migration toward these matrix proteins, whereas adhesion of chondrocytes was not influenced. This indicated the existence of functional relationships between protein tyrosine phosphorylation and chondrocyte migration following the adhesion of chondrocytes to matrix proteins. Further study showed that the peptide GRGDSP inhibited chondrocyte migration to fibronectin but not to collagens. On the other hand, chondrocytes migrated toward the tetra-RGD containing peptide, but not the peptide GRGDSP,in a dose dependent fashion. These observations suggest that cross-linking or clustering of integrins is essential to induce transmembrane signaling related to tyrosine phosphorylation for chondrocyte migration toward fibronectin.
Chondrocytesare responsible cells for the maintenance of the extracellular matrix (ECM)in cartilage tissue, which contains a variety of proteins, such as cartilage-specific proteoglycan aggrecan (1), type II collagen (2), fibronectin (3, 4), tenascin (5), and several minor collagens (6-10). Cartilage ECMis reformable, and the tissue expands when the chondrocytes divide and secrete more matrix. As chondrogenesis proceeds, type I collagen and large chondroitin sulfate proteoglycan (designated PG-M) are replaced by type II collagen and the proteoglycan aggrecan (1 1 , 12), which are known as typical markers for cartilage tissue. This dynamic change in the components of ECMproteins during chondrogenesis indicates that the ECMmay play an important role in the control of chondrocyte differentiation. Recent studies have shownthat chondrocytes are capable of attaching to a number of ECMproteins and that the integrin family of ECMreceptors is implicated in chondrocyte adhesion to ECM proteins (13-15). Enomoto et al. (16) demonstrated that /31 integrins mediate chondrocytes adhesion to type I collagen, type II collagen, and fibronectin. In many types of cells, integrin-mediated linkage of the ECMto the cytoskeleton occurs at sites known as focal adhesion (17). These sites are considered not only to have a structural function, * To whomcorrespondence should be addressed. also to serve as sites for initiating signal transduction from the ECMto the interior of the cells. Binding of adhesive ligands to integrins can induce protein tyrosine phosphorylation in fibroblasts, carcinoma cells, T lymphocytes, B cells, platelets, monocytes, and neutrophils (18-25) . Several studies concerning the capacity of signal transduction via /31 integrins have been published recently (19, (25) (26) (27) (28) (29) (30) Cell attachment assays. The cell attachment assays were performed as previously described (35). In brief, microtiter plates (Becton Dickinson Labware, Franklin Lakes, NewJersey), coated overnight with the proteins, were washed with PBS and unoccupied binding sites were blocked with \% bovine serum albumin (BSA). Cells were harvested from cell culture flask with collagenase (Boehringer Mannheim, Germany), washed with DMEM containing 10% FBS three times and then washed once with serum-free media (DMEM containing 1%BSA). Cells were counted and diluted to 1 x 106 cells /ml in serum-free media. Cell suspension (100 pX) was placed in each coated well and allowed to incubate for 45 min at 37°C. Unattached cells were washed out and attached cells were fixed with 10% formalin. Cells stained with \% toluidine blue were then counted using an inverted microscope. Cells from at least three microscope fields were counted and the mean and SD of adherent cells were determined. Cell migration assays. Chemotaxis was assayed using 24-well tissue culture plates, and cell culture inserts containing polyethylene terephthalate membranes, 8 fim pore size (Becton Dickinson Labware) as previously described (36). Triplicates of lower wells were filled with different concentrations of fibronectin, type I collagen, or type II collagen diluted in DMEM containing 1 mg/ml BSA, whereas the upper wells were filled with 4 x 105 cells/200 (A of DMEMcontaining 1 mg /ml BSA. The chambers were incubated for 5 hours in a humidified incubator at 37°C. After performing the incubation, the membranes were removed, and then fixed with methanol, stained with hematoxylin and eosin. The membranes were subsequently placed onto glass slides and remaining cells on the upper side of the membranewere wiped off. The numberof migrated cells were counted by light microscopy at 200-fold magnification. For each triplicate, the number of cells in nine microscope fields was determined and the mean and SDwere calculated.
Haptotactic assays were also performed as previously de- (xg /ml [xg /ml Promote chondrocyte Migration. Migratory chondrocytes on a membrane coated with 5 //g/ml fibronectin and non-migratory chondrocytes on a membrane coated with 1 mg/ml BSAas negative control are shown (Fig. 1) . The cells on the lower side of the membrane were fixed and stained as described in Materials and Methods. As shown in Fig. 2 This possibility was tested by the use of tyrosine kinase inhibitors. Herbimycin and genistein have been used to inhibit the signal pathway mediated by protein tyrosine kinases (37, 38) . Pretreatment of chondrocytes with herbimycin for 1 hour resulted in a dose-dependent inhibition of cell migration (Fig. 3A) . At 20 fiM, herbimycin strongly suppressed the migration promoted by ECM proteins. The inhibitory effects of genistein were noticeable at 50 fiM (Fig. 3B) . Neither herbimycin nor genistein interfered with the adhesion of chondrocytes to fibronectin, type I collagen, and type II collagen. These results indicate that tyrosine phosphorylation plays critical roles in chondrocyte migration (Table I) . A GRGDSPPeptide Inhibits Chondrocyte Migration to Fibronectin. The peptide, GRGDSP,at 1 mMconcentration, has been shown to inhibit migration of chondrocytes to fibronectin (25% of control) while migration to type I collagen and type II collagen was not influence by this peptide (Fig. 4) . This suggests that chondrocyte migration needs binding to the RGDsequence of fibronectin mediated by /3l integrin in a first vital part of the migratory response.
Cross-linking or Clustering of fil Integrins Induces
Chondrocyte Migration. To further analyze the role of /31 in chondrocyte migration, we examined the possibility of chemotactic migration promoted by the RGD sequence using two kinds of peptides, the GRGDSP and tetra-GRGDSP peptides. Ligation of integrins with the tetra-GRGDSP peptide resulted in chondrocyte migration in a dose-dependent fashion, while the GRGDSPpeptide had no effect (Fig. 5) . These observations suggest that cross-linking or clustering of integrins can produce signaling leading to chondrocyte migration because the GRGDSP peptide did not stimulate a re- Fig. 3 . Inhibition of chondrocyte migration by herbimycin or genistein. Chondrocytes were pretreated with various concentrations of herbimycin (A) or genistein (B) for 60 min at 37°C before haptotaxis toward fibronectin (10 /ig/ml), type I collagen (50 //g/ml), and type II collagen (50 fig/ml) were studied using the Boyden chamber system. is complex molecular event, involving multiple distinct cell surface receptors that interact with discrete domains on cell adhesion promoting ligands. The control of chondrocyte migration within tissues must be important for the function to maintain the fundamental structure and chondrogenesis. Within cartilages, chondrocytes are surrounded by ECMcomponents (1-10). Therefore, interactions with ECMcomponents probably play a key role for chondrocyte migration in tissues. 
